Page last updated: 2024-08-24

3-iodobenzylguanidine and Abnormalities, Cardiovascular

3-iodobenzylguanidine has been researched along with Abnormalities, Cardiovascular in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Hama, T; Hara, T; Hirayama, M; Nakamura, T; Sobue, G; Watanabe, H	1

Other Studies

1 other study(ies) available for 3-iodobenzylguanidine and Abnormalities, Cardiovascular

Article	Year
Does cardiovascular autonomic dysfunction contribute to fatigue in Parkinson's disease? Movement disorders : official journal of the Movement Disorder Society, 2011, Aug-15, Volume: 26, Issue:10 Topics: 3-Iodobenzylguanidine; Aged; Autonomic Nervous System Diseases; Blood Pressure; Cardiovascular Abnormalities; Disability Evaluation; Fatigue; Female; Heart Rate; Humans; Male; Middle Aged; Parkinson Disease; Radionuclide Imaging; Radiopharmaceuticals; Severity of Illness Index; Statistics, Nonparametric	2011

Article

Year

Does cardiovascular autonomic dysfunction contribute to fatigue in Parkinson's disease?

Movement disorders : official journal of the Movement Disorder Society, 2011, Aug-15, Volume: 26, Issue:10

Topics: 3-Iodobenzylguanidine; Aged; Autonomic Nervous System Diseases; Blood Pressure; Cardiovascular Abnormalities; Disability Evaluation; Fatigue; Female; Heart Rate; Humans; Male; Middle Aged; Parkinson Disease; Radionuclide Imaging; Radiopharmaceuticals; Severity of Illness Index; Statistics, Nonparametric

2011